LLY
787.08
-1.04%↓
JNJ
153.17
+0.49%↑
ABBV
186.31
-0.36%↓
NVO
68.75
+1.9%↑
UNH
309.27
+1.9%↑
LLY
787.08
-1.04%↓
JNJ
153.17
+0.49%↑
ABBV
186.31
-0.36%↓
NVO
68.75
+1.9%↑
UNH
309.27
+1.9%↑
LLY
787.08
-1.04%↓
JNJ
153.17
+0.49%↑
ABBV
186.31
-0.36%↓
NVO
68.75
+1.9%↑
UNH
309.27
+1.9%↑
LLY
787.08
-1.04%↓
JNJ
153.17
+0.49%↑
ABBV
186.31
-0.36%↓
NVO
68.75
+1.9%↑
UNH
309.27
+1.9%↑
LLY
787.08
-1.04%↓
JNJ
153.17
+0.49%↑
ABBV
186.31
-0.36%↓
NVO
68.75
+1.9%↑
UNH
309.27
+1.9%↑
24h
Corrente
Minimo
4.27
Massimo
4.44
Entrata | 7.3M -23M |
---|---|
Vendite | -527K 30M |
EPS | -2.77 |
Margine di Profitto | -78.168 |
Dipendenti | 279 |
EBITDA | -14M -33M |
Raccomandazioni | Fortemente da comprare |
---|---|
Previsioni per 12 mesi | +417.82% upside |
Capitalizzazione di Mercato | -15M 37M |
---|---|
Apertura precedente | 5.52 |
Chiusura precedente | 4.39 |
By Acuity
50%
50%
154 / 380 Classifica in Healthcare
By Trading Central
Fiducia
Bullish Evidence
5.9501 / 7.66 Supporto e resistenza
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
26 giu 2025, 23:49 UTC
Nike Sees Sales Decline Decelerating in 1Q as Turnaround Strategy Plays Out -- 2nd Update
DJ
LeggI
26 giu 2025, 22:19 UTC
FTC Clears Alimentation Couche-Tard's $1.57 Billion GetGo Acquisition
DJ
LeggI
26 giu 2025, 21:30 UTC
Nike 4Q Profit, Revenue Slides as Turnaround Strategy Plays Out -- Update
DJ
LeggI
26 giu 2025, 21:07 UTC
Nike 4Q Profit, Revenue Slide as Turnaround Strategy Plays Out
DJ
LeggI
26 giu 2025, 23:49 UTC
Nikkei May Rise as Fears About Middle East Conflict Ebb -- Market Talk
DJ
LeggI
26 giu 2025, 23:39 UTC
Gold Edges Lower, Weighed by Stronger-Than-Expected U.S. Data -- Market Talk
DJ
LeggI
26 giu 2025, 23:34 UTC
Wesfarmers: Lease Reset Provides Opportunity for Upgrades, Extensions
DJ
LeggI
26 giu 2025, 23:33 UTC
Wesfarmers: 62 BWP-Owned Bunnings Sites Get Significantly Longer Leases
DJ
LeggI
26 giu 2025, 23:32 UTC
Wesfarmers Will No Longer Receive Earnings From BWP Management
DJ
LeggI
26 giu 2025, 23:32 UTC
Wesfarmers to Increase BWP Holding to 23.5% From 22.3%
DJ
LeggI
26 giu 2025, 23:31 UTC
Wesfarmers: New BWP Units Priced at 9.2% Premium to Last Close
DJ
LeggI
26 giu 2025, 23:31 UTC
BWP to Pay A$100 Mln Cash, A$42.6 Mln in New Units
DJ
LeggI
26 giu 2025, 23:30 UTC
Wesfarmers' Bunnings, BWP Trust to Extend and Vary Leases
DJ
LeggI
26 giu 2025, 23:29 UTC
Wesfarmers to Sell BWP Management to BWP Trust for A$142.6M
DJ
LeggI
26 giu 2025, 23:19 UTC
Andlauer Healthcare Group: Ontario Superior Court of Justice Issues Final Order Approving Sale to UPS
DJ
LeggI
26 giu 2025, 22:06 UTC
Nike's Earnings Were Ugly. But They're Better Than Feared. -- Barrons.com
DJ
LeggI
26 giu 2025, 21:15 UTC
Nike 4Q Profit, Rev Slides as Turnaround Strategy Plays Out -- Update
DJ
LeggI
26 giu 2025, 21:07 UTC
Couche-Tard: 35 Stores to Be Divested in Accordance With Regulatory Requirements >ATD.T
DJ
LeggI
26 giu 2025, 21:07 UTC
Couche-Tard: GetGo Will Operate as Separate, Stand-Alone Business Unit, Maintain myPerks Loyalty Program >ATD.T
DJ
LeggI
26 giu 2025, 21:07 UTC
Couche-Tard: Buyer Will be Approved by the FTC >ATD.T
DJ
LeggI
26 giu 2025, 21:07 UTC
Nike's Earnings Were Ugly. But They're Better Than Feared. -- Barrons.com
DJ
LeggI
26 giu 2025, 21:06 UTC
Couche-Tard Agreed to Sell 35 Sites, Including 34 Circle K Locations and One GetGo Property >ATD.T
DJ
LeggI
26 giu 2025, 21:06 UTC
Couche-Tard: Transaction Is Expected to Close in the Coming Days >ATD.T
DJ
LeggI
26 giu 2025, 21:06 UTC
Bank of Mexico Seen Likely to Slow Pace of Rate Cuts -- Market Talk
DJ
LeggI
26 giu 2025, 21:05 UTC
COUCHE-TARD RECEIVES FTC CLEARANCE TO COMPLETE ACQUISITION OF GETGO CAFÉ + MARKET >ATD.T
DJ
LeggI
26 giu 2025, 21:05 UTC
COUCHE-TARD RECEIVES FTC CLEARANCE TO COMPLETE ACQUISITION OF GETGO CAFÉ + MARKET >ATD.T
DJ
LeggI
26 giu 2025, 20:52 UTC
Nike 4Q Profit, Rev Slide as Turnaround Strategy Plays Out
DJ
LeggI
26 giu 2025, 20:51 UTC
Correct: Nike 4Q Net $211M, Not $200M >NKE
DJ
LeggI
26 giu 2025, 20:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
LeggI
26 giu 2025, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
LeggI
Modifica del prezzo
By TipRanks
Previsioni per 12 mesi
Media 23.25 USD 417.82%
Alto 42 USD
Basso 8 USD
Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Karyopharm Therapeutics Inc - Dist negli ultimi 3 mesi.
By TipRanks
Fortemente da comprare
4 ratings
3
Acquista
1
Mantieni
0
Vendi
Basato sugli analisti di 4 che hanno fornito valutazioni azionarie a Karyopharm Therapeutics Inc - Dist negli ultimi 3 mesi.
By Trading Central
A breve termine
Bullish Evidence
Recent bullish events outweigh bearish events.
A termine intermedio
Strong Bearish Evidence
All events are bearish.
A lungo termine
No Evidence
There are no events.
By Acuity
Notizie sul Sentiment di mercato
Neutral
Volatilità
Sotto la media
Volume delle notizie (RCV)
Sotto la media
Spese di vendita e di amministrazione
Spese operative
Utile prima delle imposte
Vendite
Costo delle vendite
Utile lordo sulle vendite
Interessi passivi sul debito
EBITDA
Utile operativo
$